Introducing Formation Bio

We are excited to share that TrialSpark has renamed and rebranded to Formation Bio! While our name is changing, our founding mission is steadfast: to bring new treatments to patients faster and more efficiently.

Our early years - and the TrialSpark name - were focused on sparking innovation within clinical trials, building clinical trial technology tools for drug developers, including software and platforms for digital patient recruitment and site management. We subsequently advanced to operating as a CRO, running end-to-end trials for sponsors, leveraging our in-house platform. Then, building on those capabilities, we evolved to acquiring and developing our own drugs.

Our model and capabilities have grown to serve our bigger vision of building the pharma company of the future. Our drug development platform has matured across R&D and tech, and we have established - and continue to grow - our own pipeline of majority owned assets. Now, our brand reflects this identity.

Formation Bio

Formation Bio is setting a new standard for the pace of drug development. We're a tech-driven pharma company, bringing together technical depth, pharma acumen, and an enterprising spirit to shave years off the time it takes to bring new treatments to patients safely.

Together, we are forming a drug development platform that optimizes all aspects of clinical drug development, enabling
more efficient protocol and program design, faster clinical trial completion, and increased quality throughout.

At Formation Bio, everything we do is motivated by the knowledge that every day counts for patients waiting for new treatments.
Time is of the essence. The world is waiting for radically more efficient drug development, and we are answering the call.

What changes to expect

Effective December 5th, 2023 we will be doing business as Formation Bio. We invite you to explore our new website and get a feel for our new visual brand. The back-end transition will take some time, and you may continue to see TrialSpark in some instances. (Software, documentation, billing etc.) The full transition will take place gradually in 2024.

Learn more about Formation Bio’s model here.